Optimizing HEALing in Ohio Communities (OHiO)
优化俄亥俄州社区的治疗 (OHiO)
基本信息
- 批准号:9917751
- 负责人:
- 金额:$ 2077.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-17 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcute Hepatitis CAddressAdoptedAdoptionAffectAgeAmericasBirthCaringCharacteristicsClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthCountyCounty GovernmentCriminal JusticeDataData AnalyticsDeath RateDecision MakingEffectivenessEvidence based interventionFamilyFosteringFundingGoalsHealthHealthcareInfrastructureInterventionInvestmentsJusticeLearningMaintenanceMedicalModelingMorbidity - disease rateNaloxoneNational Institute of Drug AbuseNeonatal Abstinence SyndromeOhioOpioidOutcomeOverdoseParentsPatientsPenetrationPersonsPoliciesPreparationPreventionPublic HealthRandomizedRecoveryReportingReproducibilityResearch PersonnelResourcesRuralRural CommunityService delivery modelServicesSiteState GovernmentStructureSystemTestingTimeTrainingTranslatingUniversitiesVirus DiseasesWorkbasebehavioral healthcommunity centercommunity settingcost effectivenessdesigneffectiveness evaluationevidence basehealinghealth assessmenthealthcare communityincremental cost-effectivenessmortalityopioid epidemicopioid misuseopioid mortalityopioid overdoseopioid use disorderoverdose deathpaymentprescription opioidpreventprogramsrural countiessecondary outcomeservice coordinationsuccessteacherurban area
项目摘要
PROJECT SUMMARY
The opioid epidemic has become entrenched in Ohio, with an age-adjusted opioid-related overdose death rate
of 32.9/100,000 people (2017), ranking second nationally. Neither rural nor urban areas have been spared,
with 38 of Ohio’s 88 counties (43%) reporting opioid-related deaths exceeding 25/100,000 people.
Since 2012, Ohio has mounted an unprecedented effort to reduce opioid use disorder (OUD) morbidity and
mortality through policies and investments in prevention, treatment, and recovery efforts. However, challenges
inherent in integrating and deploying evidence-based interventions (EBI) across sectors has limited their
impact in affected communities.
The goal of Optimizing Healing in Ohio Communities (OHiO) is to systematically plan, implement, and evaluate
data-driven approaches that integrate multi-pronged EBI within healthcare, behavioral health, justice systems,
and communities to reduce opioid overdose deaths in 19 highly affected counties by 40% in 3 years. OHiO is
anchored by three NCATS-funded CTSAs and the NIDA-funded Ohio Valley Node of the Clinical Trials
Network and leverages extensive existing collaborations with community coalitions, state and county
governments, and healthcare, behavioral health and criminal justice sectors. OHiO’s approach is based upon
and aligned with the state-mandated Community Health Assessments and Community Health Improvement
Plans, leveraging state and federally funded programs already in place. The overarching goal will be met
through completion of three aims. Aim 1) Plan: We will assess current policies/programs regarding OUD,
opioid misuse, and opioid-related fatalities; using the Exploration, Adoption/Preparation, Implementation and
Sustainment model, work with communities to select EBI to reduce OUD and overdose deaths; and identify
gaps in services/service coordination that are amenable to intervention. Aim 2) Implement: Through a
pragmatic community-based clinical trial, we will deliver EBI packages using a cluster stepped-wedge design in
which collaborating communities are randomized by the timing of which selected interventions are received.
Aim 3) Evaluate: We will continuously collect and analyze data using the Reach, Efficacy, Adoption,
Implementation, and Maintenance (RE-AIM) model to assess the impact of the integrated interventions and
implementation outcomes including acceptability, adoption (including fidelity to the intervention), feasibility,
penetration, and incremental cost and cost-effectiveness of the multipronged approach. We will also establish
Learning Health Communities to provide community stakeholders access to real-time, actionable information.
Ultimately, OHiO will provide rigorous and reproducible evidence of the effectiveness of integrated prevention,
treatment, and recovery programs in the community context; an exportable and scalable model of service
assessment, community-engaged decision-making; and integrated, data-driven EBI that can be implemented
by affected communities in Ohio, the region, and across the US.
项目概要
阿片类药物流行病在俄亥俄州已根深蒂固,与年龄调整的阿片类药物相关的过量死亡率
32.9/10万人(2017年),全国排名第二,农村和城市都未能幸免。
俄亥俄州 88 个县中有 38 个县 (43%) 报告与阿片类药物相关的死亡人数超过 25/100,000 人。
自 2012 年以来,俄亥俄州采取了前所未有的努力来减少阿片类药物使用障碍 (OUD) 的发病率和
通过预防、治疗和恢复工作的政策和投资来降低死亡率 然而,挑战也存在。
跨部门整合和部署循证干预措施 (EBI) 所固有的限制了其
对受影响社区的影响。
优化俄亥俄州社区康复 (OHiO) 的目标是系统地规划、实施和评估
数据驱动的方法,将多管齐下的 EBI 整合到医疗保健、行为健康、司法系统、
OHiO 计划在 3 年内将 19 个受影响严重的县的阿片类药物过量死亡人数减少 40%。
由三个 NCATS 资助的 CTSA 和 NIDA 资助的俄亥俄谷临床试验节点支持
建立网络并利用与社区联盟、州和县的广泛现有合作
OHiO 的方法基于政府、医疗保健、行为健康和刑事司法部门。
并与国家规定的社区健康评估和社区健康改善保持一致
利用州和联邦资助的计划,已经到位的总体目标将得到实现。
通过完成三个目标 1) 计划:我们将评估有关 OUD 的现行政策/计划,
阿片类药物滥用以及与阿片类药物相关的死亡;使用探索、采用/准备、实施和
维持模式,与社区合作选择 EBI 来减少 OUD 和过量死亡;
需要干预的服务/服务协调方面的差距 目标 2) 实施:通过
基于务实的社区临床试验,我们将使用集群阶梯楔形设计提供 EBI 包
哪些合作社区是根据收到选定干预措施的时间随机分配的。
目标 3) 评估:我们将使用覆盖率、功效、采用率、
实施和维护(RE-AIM)模型,用于评估综合干预措施的影响和
实施结果包括可接受性、采用(包括对干预措施的忠诚度)、可行性、
我们还将建立多管齐下的渗透率、增量成本和成本效益。
学习健康社区为社区利益相关者提供实时、可操作的信息。
最终,OHiO 将提供严格且可重复的证据来证明综合预防的有效性,
社区背景下的治疗和康复计划;可输出且可扩展的服务模式;
评估、社区参与决策;以及可实施的综合、数据驱动的 EBI
俄亥俄州、该地区以及美国各地受影响的社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
REBECCA D JACKSON其他文献
REBECCA D JACKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('REBECCA D JACKSON', 18)}}的其他基金
Enhancing Cancer Focused Education for Tomorrow’s Workforce – Coordinating Center
加强对未来劳动力的癌症教育 — 协调中心
- 批准号:
10377587 - 财政年份:2020
- 资助金额:
$ 2077.93万 - 项目类别:
Enhancing Cancer Focused Education for Tomorrow’s Workforce – Coordinating Center
加强对未来劳动力的癌症教育 — 协调中心
- 批准号:
9905248 - 财政年份:2020
- 资助金额:
$ 2077.93万 - 项目类别:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
- 批准号:
10197479 - 财政年份:2018
- 资助金额:
$ 2077.93万 - 项目类别:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
- 批准号:
9975951 - 财政年份:2018
- 资助金额:
$ 2077.93万 - 项目类别:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
- 批准号:
10474122 - 财政年份:2018
- 资助金额:
$ 2077.93万 - 项目类别:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
- 批准号:
10158940 - 财政年份:2018
- 资助金额:
$ 2077.93万 - 项目类别:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
- 批准号:
10171422 - 财政年份:2018
- 资助金额:
$ 2077.93万 - 项目类别:
Long-term Outcomes of Knee OA in the OAI Cohort
OAI 队列中膝关节 OA 的长期结果
- 批准号:
9977059 - 财政年份:2017
- 资助金额:
$ 2077.93万 - 项目类别:
Long-term Outcomes of Knee OA in the OAI Cohort
OAI 队列中膝关节 OA 的长期结果
- 批准号:
9125680 - 财政年份:2017
- 资助金额:
$ 2077.93万 - 项目类别:
The Ohio State University Center for Clinical and Translational Science
俄亥俄州立大学临床和转化科学中心
- 批准号:
8720959 - 财政年份:2013
- 资助金额:
$ 2077.93万 - 项目类别:
相似海外基金
Estimating the population size of persons who inject drugs in New York
估计纽约注射吸毒者的人口规模
- 批准号:
10705455 - 财政年份:2022
- 资助金额:
$ 2077.93万 - 项目类别:
Increasing representation of black communities in SARS-CoV-2 serosurveys by understanding barriers and motivations for participation
通过了解参与的障碍和动机,增加黑人社区在 SARS-CoV-2 血清调查中的代表性
- 批准号:
10843497 - 财政年份:2021
- 资助金额:
$ 2077.93万 - 项目类别:
Estimating the population size of persons who inject drugs in New York
估计纽约注射吸毒者的人口规模
- 批准号:
10347333 - 财政年份:2020
- 资助金额:
$ 2077.93万 - 项目类别:
Optimizing HEALing in Ohio Communities (OHiO)
优化俄亥俄州社区的治疗 (OHiO)
- 批准号:
10388335 - 财政年份:2019
- 资助金额:
$ 2077.93万 - 项目类别:
Drew MIDARP (Infrastructure in Drug Abuse Research)
Drew MIDARP(药物滥用研究基础设施)
- 批准号:
7494900 - 财政年份:2004
- 资助金额:
$ 2077.93万 - 项目类别: